Implementation of a pharmaceutical care programme for patients receiving new molecular-targeted agents in a clinical trial unit

European Journal of Cancer Care
G RiuL Vidal

Abstract

A pharmaceutical care programme was implemented at our hospital in early 2013. The main objectives were to analyse and describe the pharmaceutical interventions made, to calculate adherence, interventions and to evaluate patient satisfaction with the care programme. We performed a single-centre descriptive and prospective intervention in cancer patients who received oral chemotherapy as part of a clinical trial in 2013. Eighty-three patients were included. Median age was 58 years (range, 31-80) and 42 patients (50.6%) were men. We recorded 23 interventions, 13 of which were associated with drug interactions. The mean percentage of adherence was 98.9%. The interview with the pharmacist was considered to be very important by 84.6% of the respondents. A total of 92.3% said that they would like to speak to the pharmacist at subsequent visits. The doubts detected during the visits enable us to conclude that the information patients receive with respect to their study medication is usually incomplete. An integrated pharmaceutical care programme for cancer patients participating in clinical trials with oral cytostatic drugs was successful in terms of adherence and patient satisfaction and makes it possible to guarantee the safety and ...Continue Reading

References

May 18, 1991·Lancet·J Urquhart
Apr 1, 1996·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·M R CohenJ M Pruemer
May 2, 2002·Journal of the National Cancer Institute·Ann H PartridgeEric P Winer
Sep 3, 2004·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Ian ChauPierre Fumoleau
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Oct 1, 2005·Cancer Investigation·Isa E L M KuppensJ H M Schellens
Nov 4, 2005·The New England Journal of Medicine·Ronald J Campbell
May 1, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Joseph Aisner
Oct 2, 2007·Pharmacy World & Science : PWS·Ulrich JaehdeMartina Westfeld
Nov 28, 2008·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Louise DelaneyJacob Easaw
Jan 17, 2009·CA: a Cancer Journal for Clinicians·Kathryn RuddyAnn Partridge
Aug 29, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R P Riechelmann, A Del Giglio
Jan 21, 2011·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Aimee Danette RuderFrederic Henry Kass
Jun 12, 2013·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·J Cotrina LuqueL Fernández Fernández

❮ Previous
Next ❯

Citations

Oct 17, 2018·European Journal of Cancer Care·Gisela Riu-ViladomsNatàlia Creus
Oct 28, 2018·International Journal of Clinical Pharmacy·Mar Saavedra-MitjansJean-François Bussières
Jan 4, 2020·Journal of the National Cancer Institute·Shoshana M RosenbergAnn H Partridge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.